We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$3.71B
AUM Growth
+$963M
Cap. Flow
+$908M
Cap. Flow %
24.49%
Top 10 Hldgs %
38.05%
Holding
132
New
49
Increased
24
Reduced
12
Closed
44

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$105M
2
AMZN icon
Amazon
AMZN
+$62.3M
3
AVGO icon
Broadcom
AVGO
+$57.6M
4
TSN icon
Tyson Foods
TSN
+$56.8M
5
MDVN
MEDIVATION, INC.
MDVN
+$52M

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$61.6M
2
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$40.6M
3
HPQ icon
HP
HPQ
+$31.9M
4
UNFI icon
United Natural Foods
UNFI
+$24.6M
5
ANF icon
Abercrombie & Fitch
ANF
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 12.26%
2 Consumer Discretionary 9.59%
3 Technology 6.55%
4 Consumer Staples 5.53%
5 Communication Services 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYGN icon
76
PUT
Myriad Genetics
MYGN
$303M
$10.2M 0.28%
300,000
+200,000
+200% +$7.1M
AHD
77
CALL
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
$7.79M 0.21%
250,000
-2,950,000
-92% -$91.9M
ELDN icon
78
Eledon Pharmaceuticals
ELDN
$269M
$7.62M 0.21%
3,191
+228
+8% +$541K
GLOG
79
CALL
DELISTED
GASLOG LTD
GLOG
$5.29M 0.14%
+260,000
New +$5.1M
ARP
80
DELISTED
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
$5.16M 0.14%
+482,000
New +$7.07M
GLOG
81
PUT
DELISTED
GASLOG LTD
GLOG
$5.09M 0.14%
+250,000
New +$4.9M
VVUS
82
PUT
DELISTED
Vivus Inc
VVUS
$5.04M 0.14%
175,000
– –
AVGO icon
83
CALL
Broadcom
AVGO
$1.99T
$5.03M 0.14%
+500,000
New +$4.47M
DYAX
84
DELISTED
DYAX CORPORATION
DYAX
$4.92M 0.13%
+350,000
New +$4.38M
AVG
85
CALL
DELISTED
AVG Technologies N.V.
AVG
$4.44M 0.12%
+225,000
New +$4.15M
FOLD
86
DELISTED
Amicus Therapeutics
FOLD
$4.16M 0.11%
+500,000
New +$3.43M
AHD
87
DELISTED
ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE)
AHD
$3.11M 0.08%
+99,893
New +$3.11M
RGLS
88
PUT
DELISTED
Regulus Therapeutics
RGLS
$1.6M 0.04%
+833
New +$1.48M
ABUS icon
89
PUT
Arbutus Biopharma
ABUS
$873M
– –
-200,000
Closed -$4.23M
ANF icon
90
CALL
Abercrombie & Fitch
ANF
$4.9B
– –
-400,000
Closed -$14.5M
ANF icon
91
Abercrombie & Fitch
ANF
$4.9B
– –
-650,000
Closed -$23.6M
CME icon
92
PUT
CME Group
CME
$94.4B
– –
-250,000
Closed -$20M
DG icon
93
PUT
Dollar General
DG
$28.1B
– –
-250,000
Closed -$15.3M
DIA icon
94
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.5B
– –
-1,250,000
Closed -$213M
DLTR icon
95
Dollar Tree
DLTR
$25.1B
– –
-370,000
Closed -$20.7M
GM icon
96
CALL
General Motors
GM
$77.5B
– –
-500,000
Closed -$16M
GPRO icon
97
CALL
GoPro
GPRO
$133M
– –
-100,000
Closed -$9.37M
GPRO icon
98
PUT
GoPro
GPRO
$133M
– –
-100,000
Closed -$9.37M
GS icon
99
PUT
Goldman Sachs
GS
$311B
– –
-500,000
Closed -$91.8M
HPQ icon
100
CALL
HP
HPQ
$26.4B
– –
-3,963,600
Closed -$63.8M
2 3
4
5 6

Similar funds

BC
Blueport Capital Fort Worth, Texas $5.8M AUM 4.95% 1-Year Est. Return
LBG
Lloyds Banking Group London, United Kingdom $7.15M AUM 0.75% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
ACM
Archer Capital Management New York $16.2M AUM 17.01% 1-Year Est. Return
MGFS
Miller Green Financial Services Spring, Texas $17.6M AUM
LA
Lexington Advisors New York $18.7M AUM 48.36% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
NMM
NGP MR Management Dallas, Texas $23.4M AUM 15.8% 1-Year Est. Return

Tourbillon Capital Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Tourbillon Capital Partners held 132 positions worth $3.71B, up 35% from $2.74B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tourbillon Capital Partners deployed $908M of net new capital in Q4 2014, opening 49 new positions and adding to 24 existing holdings. Its largest new stake was Bausch Health: 780,000 shares worth $112M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was AMAG Pharmaceuticals, an estimated $15M trimmed.

  • Tourbillon Capital Partners's largest Q4 2014 buy was Bausch Health: 780,000 shares worth $112M.
  • Tourbillon Capital Partners added most to Tyson Foods in Q4 2014, an estimated $56.8M increase.
  • Tourbillon Capital Partners's biggest Q4 2014 reduction was AMAG Pharmaceuticals, cutting an estimated $15M.
  • Tourbillon Capital Partners fully exited NXP Semiconductors in Q4 2014, selling an estimated $61.6M.
  • Tourbillon Capital Partners's ten largest holdings make up 38% of its $3.71B portfolio in Q4 2014.
  • Tourbillon Capital Partners opened 49 new positions and closed 44 in Q4 2014.
  • Tourbillon Capital Partners's portfolio value rose 35% quarter-over-quarter to $3.71B.

Based on Tourbillon Capital Partners's 13F filing for Q4 2014, filed 17 Feb 2015.